Gene Rearrangements Molecular Flashcards
Which tumors have NTRK fusions?
Congenital infantile fibrosarcoma, congenital mesoblastic nephroma, glioblastomas, acute myeloid leukemia, secretory breast carcinoma, mammary analogue secretory carcinoma, inflammatory myofibroblastic tumor, and some lung cancers
t(12;15)(p13;q26) with ETV6-NTRK3 fusion in CIFS
Mucoepidermoid carcinoma
Mucoepidermoid carcinoma is characterized by MECT1-MAML2 fusion transcripts with a unique translocation t(11;19)(q21;p13)
MECT-MAML2
mucoepidermoid carcinoma, t(11;19)(q21;p13)
t(11;19)(q21;p13)
Mucoepidermoid carcinoma, MECT1-MAML2
Ewing’s Sarcoma
EWSR-FLI1 rearrangement involving t(11;22)
EWSR-FLI1
Ewing’s sarcoma, t(11;22)
t(11:22)
Ewing’s sarcoma, EWSR-FLI1
Myxoid liposarcoma
FUS-DDIT3 gene fusions or EWSR1-DDIT3
FUS-DDIT3 gene fusions or EWSR1-DDIT3
Myxoid liposarcoma
Acral fibromyxoma
Loss of 13q12 (RB1), Similar to spindle cell lipoma
Loss of 13q12
Acral fibromyxoma or spindle cell lipoma; Rb1
Rb1
Loss of 13q12, acral fibromyxoma or spindle cell lipoma.
Alveolar rhabdomyosarcoma
- t(2;13)(q35;q14) with PAX3-FOXO1 fusion (60% of cases and worse prognosis, more aggressive)
- t(1;13)(p36;q14) with PAX7-FOXO1 fusion
PAX3-FOXO1
Alveolar rhabdomyosarcoma
- t(2;13)(q35;q14) with PAX3-FOXO1 fusion (60% of cases and worse prognosis, more aggressive)
- t(1;13)(p36;q14) with PAX7-FOXO1 fusion
PAX7-FOXO1
Alveolar rhabdomyosarcoma
- t(2;13)(q35;q14) with PAX3-FOXO1 fusion (60% of cases and worse prognosis, more aggressive)
- t(1;13)(p36;q14) with PAX7-FOXO1 fusion
t(2;13)(q35;q14)
Alveolar rhabdomyosarcoma
- t(2;13)(q35;q14) with PAX3-FOXO1 fusion (60% of cases and worse prognosis, more aggressive)
- t(1;13)(p36;q14) with PAX7-FOXO1 fusion
t(1;13)(p36;q14)
Alveolar rhabdomyosarcoma
- t(2;13)(q35;q14) with PAX3-FOXO1 fusion (60% of cases and worse prognosis, more aggressive)
- t(1;13)(p36;q14) with PAX7-FOXO1 fusion
Alveolar soft part sarcoma
der(17)t(X;17)(p11;q25) with ASPSCR1-TFE3 fusion
ASPSCR1-TFE3
Alveolar soft part sarcoma; der(17)t(X;17)(p11;q25) with ASPSCR1-TFE3 fusion
der(17)t(X;17)(p11;q25)
Alveolar soft part sarcoma; der(17)t(X;17)(p11;q25) with ASPSCR1-TFE3 fusion
Aneurysmal bone cyst of soft tissue
Aneurysmal bone cyst of soft tissue; 17p13 rearrangements, USP6 gene
17p13
Aneurysmal bone cyst of soft tissue; 17p13 rearrangements, USP6 gene
USP6
Aneurysmal bone cyst of soft tissue; 17p13 rearrangements, USP6 gene
Angiofibroma of soft tissue
Angiofibroma of soft tissue; t(5;8)(p15;q13) with AHRR-NCOA2 fusion
t(5;8)(p15;q13)
Angiofibroma of soft tissue; t(5;8)(p15;q13) with AHRR-NCOA2 fusion
AHRR-NCOA2
Angiofibroma of soft tissue; t(5;8)(p15;q13) with AHRR-NCOA2 fusion
Angiosarcoma
Angiosarcoma; Amplification of 8q24 (MYC)
8q24
Angiosarcoma; Amplification of 8q24 (MYC)
Atypical spindle cell lipomatous tumor
Atypical spindle cell lipomatous tumor; Loss of 13q14 (RB1); Similar to spindle cell lipoma, cellular angiofibroma, mammary-type myofibroblastoma, acral fibromyxoma
13q14
Atypical spindle cell lipomatous tumor; Loss of 13q14 (RB1); Similar to spindle cell lipoma, cellular angiofibroma, mammary-type myofibroblastoma, acral fibromyxoma
Atypical lipomatous tumor/well diff liposarcoma/de-diff liposarcoma
Atypical lipomatous tumor; Ring form of chromosome 12; amplification of MDM2, CDK4, CPM
Ring chr12
Atypical lipomatous tumor; Ring form of chromosome 12; amplification of MDM2, CDK4, CPM
MDM2
Atypical lipomatous tumor; Ring form of chromosome 12; amplification of MDM2, CDK4, CPM
Angiomatoid fibrous histiocytoma, clear cell sarcoma, malignant gastrointestinal neuroectodermal tumor
Angiomatoid fibrous histiocytoma;
- t(2;22)(q33;q12) with EWSR1-CREB1 fusion
- t(12;22)(q13;q12) with EWSR1-ATF1 fusion
t(2;22) most common (90% of cases); also present in clear cell sarcoma and malignant gastrointestinal neuroectodermal tumor
- t(2;22)(q33;q12)
2. t(12;22)(q13;q12)
Angiomatoid fibrous histiocytoma;
- t(2;22)(q33;q12) with EWSR1-CREB1 fusion
- t(12;22)(q13;q12) with EWSR1-ATF1 fusion
t(2;22) most common (90% of cases); also present in clear cell sarcoma and malignant gastrointestinal neuroectodermal tumor
EWSR1-CREB1 fusion
EWSR1-ATF1 fusion
Angiomatoid fibrous histiocytoma;
- t(2;22)(q33;q12) with EWSR1-CREB1 fusion
- t(12;22)(q13;q12) with EWSR1-ATF1 fusion
t(2;22) most common (90% of cases); also present in clear cell sarcoma and malignant gastrointestinal neuroectodermal tumor
Deep aggressive angiomyxoma
Deep aggressive angiomyxoma; Rearrangements of 12q14.3; HMGA2
12q14.3
Deep aggressive angiomyxoma; Rearrangements of 12q14.3; HMGA2
Dermatofibrosarcoma protuberans (DFSP) , giant cell fibroblastoma
Dermatofibrosarcoma protuberans (DFSP); t(17;22)(q21;q13) with COL1A1-PDGFB fusion
t(17;22)(q21;q13)
Dermatofibrosarcoma protuberans (DFSP); t(17;22)(q21;q13) with COL1A1-PDGFB fusion
COL1A1-PDGFB
Dermatofibrosarcoma protuberans (DFSP); t(17;22)(q21;q13) with COL1A1-PDGFB fusion
Desmoid-type fibromatosis
Desmoid-type fibromatosis; CTNNB1 (β-catenin gene) mutations in sporadic lesions; APC mutations in tumors arising within setting of Gardner syndrome
CTNNB1
Desmoid-type fibromatosis; CTNNB1 (β-catenin gene) mutations in sporadic lesions; APC mutations in tumors arising within setting of Gardner syndrome
Desmoplastic small round cell tumor
Desmoplastic small round cell tumor; t(11;22)(p13;q12) with EWSR1-WT1 fusion
t(11;22); (p13;q12)
Desmoplastic small round cell tumor; t(11;22)(p13;q12) with EWSR1-WT1 fusion
EWSR1-WT1
Desmoplastic small round cell tumor; t(11;22)(p13;q12) with EWSR1-WT1 fusion
Epithelioid hemangioendothelioma
Epithelioid hemangioendothelioma; t(1;3)(p36.3;q23-25) with WWTR1-CAMTA1 fusion
t(1;3)(p36.3;q23-25)
Epithelioid hemangioendothelioma; t(1;3)(p36.3;q23-25) with WWTR1-CAMTA1 fusion
WWTR1-CAMTA1
Epithelioid hemangioendothelioma; t(1;3)(p36.3;q23-25) with WWTR1-CAMTA1 fusion
Epithelioid hemangioma
Epithelioid hemangioma; FOS rearrangements (14q24.3)
FOS
Epithelioid hemangioma; FOS rearrangements (14q24.3)
14q24.3
Epithelioid hemangioma; FOS rearrangements (14q24.3)
Epithelioid fibrous histiocytoma and inflammatory myofibroblastic tumor
Epithelioid fibrous histiocytoma and inflammatory myofibroblastic tumor; 2p23 (ALK gene) rearrangements
2p23
Epithelioid fibrous histiocytoma and inflammatory myofibroblastic tumor; 2p23 (ALK gene) rearrangements
Epithelioid sarcoma
Epithelioid sarcoma; 22q11-12 abnormalities; Inactivation of SMARCB1 (a.k.a. INI1 or SNF5)
22q11-12
Epithelioid sarcoma; 22q11-12 abnormalities; Inactivation of SMARCB1 (a.k.a. INI1 or SNF5)
SMARCB1 or INI1 (tons of tumors)
Epithelioid sarcoma, Extrarenal rhabdoid tumor; 22q11-12 abnormalities
Gastrointestinal stromal tumor
GIST
KIT, PDGFRA mutations
Rare: Mutations in SDH subunit genes (usually SDHB) or NF1
Kit and PDGFRA, SDHB mutations
GIST
KIT, PDGFRA mutations
Rare: Mutations in SDH subunit genes (usually SDHB) or NF1
Hibernoma
Hibernoma; 11q13 rearrangements
11q13
Hibernoma; 11q13 rearrangements
t(12;15)(p13;q26) with ETV6-NTRK3 fusion
Congenital infantile fibrosarcoma, congenital mesoblastic nephroma, glioblastomas, acute myeloid leukemia, secretory breast carcinoma, mammary analogue secretory carcinoma, inflammatory myofibroblastic tumor, and some lung cancers
t(12;15)(p13;q26) with ETV6-NTRK3 fusion in CIFS
ETV6-NTRK3 fusion
Congenital infantile fibrosarcoma, congenital mesoblastic nephroma, glioblastomas, acute myeloid leukemia, secretory breast carcinoma, mammary analogue secretory carcinoma, inflammatory myofibroblastic tumor, and some lung cancers
t(12;15)(p13;q26) with ETV6-NTRK3 fusion in CIFS
Intramuscular myxoma
Intramuscular myxoma; GNAS gene mutations
GNAS gene mutations
Intramuscular myxoma; GNAS gene mutations
NUT carcinoma
NUT carcinoma; t(15;19) BRD4-NUTM1 fusion
BRD4-NUTM1 fusion
NUT carcinoma; t(15;19) BRD4-NUTM1 fusion
t(15:19)
NUT carcinoma; t(15;19) BRD4-NUTM1 fusion